Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

NZX 50 stumbles as Ebos losses mount
Markets Market Close

NZX 50 stumbles as Ebos losses mount

The NZX 50 has erased Monday's gains. 

Gregor Thompson 09 Sep 2025
Most Asian markets rise on US rate hopes
Markets

Most Asian markets rise on US rate hopes

Investors are awaiting the release of fresh data on prices this week.

AFP 09 Sep 2025
No big NZ cuts amid 'Nuno-geddon': ANZ NZ
Finance

No big NZ cuts amid 'Nuno-geddon': ANZ NZ

ANZ Group chops thousands of staff, contractors, but no big cuts in NZ. 

Andy Macdonald 09 Sep 2025
Vista's new shareholders revealed
Markets

Vista's new shareholders revealed

Flurry of NZX notices show who's been buying Vista shares – and selling too.